Edward L. Korn

Also affiliated with National Cancer Institute

MathematicsEconomics, Econometrics and FinanceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Are restricted mean survival time methods especially useful for noninferiority trials?”.

Are restricted mean survival time methods especially useful for noninferiority trials?

Clinical Trials(2021)10.1177/1740774520976576

N/A

1.2DataRank · unranked

15 citations

Chen Hu, Edward L. Korn, Boris Freidlin

Reply to Quartagno et al.

Clinical Trials(2021)10.1177/17407745211045123

N/A

0DataRank · unranked

1 citations

Chen Hu, Edward L. Korn, Boris Freidlin

Augmenting randomized clinical trial data with historical control data: Precision medicine applications

JNCI Journal of the National Cancer Institute(2022)10.1093/jnci/djac185

N/A

0DataRank · unranked

22 citations

Edward L. Korn, Boris Freidlin

Avoiding Delays in Reporting Time-to-Event Randomized Trials: Calendar Backstops and Other Approaches

Journal of Clinical Oncology(2024)10.1200/jco.24.00025

N/A

0DataRank · unranked

7 citations

Boris Freidlin, Edward L. Korn, Megan Othus

Two-to-One Randomization: Rarely Advisable

JCO Oncology Practice(2024)10.1200/op.24.00217

N/A

0DataRank · unranked

6 citations

Edward L. Korn, Boris Freidlin